777 related articles for article (PubMed ID: 30333031)
21. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
22. Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.
Sielska M; Przanowski P; Pasierbińska M; Wojnicki K; Poleszak K; Wojtas B; Grzeganek D; Ellert-Miklaszewska A; Ku MC; Kettenmann H; Kaminska B
Br J Cancer; 2020 Aug; 123(3):438-448. PubMed ID: 32390004
[TBL] [Abstract][Full Text] [Related]
23. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.
Kohanbash G; Carrera DA; Shrivastav S; Ahn BJ; Jahan N; Mazor T; Chheda ZS; Downey KM; Watchmaker PB; Beppler C; Warta R; Amankulor NA; Herold-Mende C; Costello JF; Okada H
J Clin Invest; 2017 Apr; 127(4):1425-1437. PubMed ID: 28319047
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
25. Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas.
Xu R; Han M; Xu Y; Zhang X; Zhang C; Zhang D; Ji J; Wei Y; Wang S; Huang B; Chen A; Zhang Q; Li W; Sun T; Wang F; Li X; Wang J
J Transl Med; 2017 Jul; 15(1):165. PubMed ID: 28754121
[TBL] [Abstract][Full Text] [Related]
26. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
27. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
28. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Wang H; Jiang C
Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
[TBL] [Abstract][Full Text] [Related]
29. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
30. Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas.
Kao Y; Tsai WC; Chen SH; Hsu SY; Huang LC; Chang CJ; Huang SM; Hueng DY
Sci Rep; 2021 Sep; 11(1):18541. PubMed ID: 34535705
[TBL] [Abstract][Full Text] [Related]
31. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
[TBL] [Abstract][Full Text] [Related]
32. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
33. The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells.
Flinck M; Kramer SH; Schnipper J; Andersen AP; Pedersen SF
Cell Cycle; 2018; 17(9):1056-1067. PubMed ID: 29895196
[TBL] [Abstract][Full Text] [Related]
34. Tumor microenvironment conditions alter Akt and Na
Pedersen AK; Mendes Lopes de Melo J; Mørup N; Tritsaris K; Pedersen SF
BMC Cancer; 2017 Aug; 17(1):542. PubMed ID: 28806945
[TBL] [Abstract][Full Text] [Related]
35. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
36. Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival.
Toft NJ; Axelsen TV; Pedersen HL; Mele M; Burton M; Balling E; Johansen T; Thomassen M; Christiansen PM; Boedtkjer E
Elife; 2021 Jul; 10():. PubMed ID: 34219652
[TBL] [Abstract][Full Text] [Related]
37. FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
Wang Z; Zhang C; Sun L; Liang J; Liu X; Li G; Yao K; Zhang W; Jiang T
Oncotarget; 2016 Dec; 7(51):84587-84593. PubMed ID: 27829236
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
Lin HH; Tsai WC; Tsai CK; Chen SH; Huang LC; Hueng DY; Hung KC
J Mol Neurosci; 2021 Aug; 71(8):1614-1621. PubMed ID: 33641091
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma.
Di K; Lomeli N; Wood SD; Vanderwal CD; Bota DA
Oncotarget; 2016 Nov; 7(47):77457-77467. PubMed ID: 27764809
[TBL] [Abstract][Full Text] [Related]
40. [Effects of Na(+) /H(+) exchanger 1 inhibitor on intestinal injury of rats with burn sepsis and the mechanism].
Li WP; Zhao GY; Yang XK
Zhonghua Shao Shang Za Zhi; 2017 Jun; 33(6):349-354. PubMed ID: 28648038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
